Last reviewed · How we verify
Preserved latanoprost 0.005% — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Preserved latanoprost 0.005% (Preserved latanoprost 0.005%) — Medical University of Vienna.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Preserved latanoprost 0.005% TARGET | Preserved latanoprost 0.005% | Medical University of Vienna | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Preserved latanoprost 0.005% CI watch — RSS
- Preserved latanoprost 0.005% CI watch — Atom
- Preserved latanoprost 0.005% CI watch — JSON
- Preserved latanoprost 0.005% alone — RSS
Cite this brief
Drug Landscape (2026). Preserved latanoprost 0.005% — Competitive Intelligence Brief. https://druglandscape.com/ci/preserved-latanoprost-0-005. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab